|Articles|November 15, 2018
Quanticate Sponsors PhD Research into Response-Adaptive Trial Design
Advertisement
Quanticate, a data-focused CRO, has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomization.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5